NNVC
NanoViricides·AMEX
--
--(--)
--
--(--)
NNVC Filings
Filing Date
Form Description
Form Type
2026-02-25
Form D - Notice of Exempt Offering of Securities
2026-02-25 ·
Form D - Notice of Exempt Offering of Securities
2026-02-17
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Financials
2026-02-17 · Financials
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025-12-30
Form 424B3 - Prospectus [Rule 424(b)(3)]
2025-12-30 ·
Form 424B3 - Prospectus [Rule 424(b)(3)]
2025-12-22
Form EFFECT - Notice of Effectiveness
2025-12-22 ·
Form EFFECT - Notice of Effectiveness
2025-12-16
Form DEL AM - Delaying amendment
2025-12-16 ·
Form DEL AM - Delaying amendment
2025-12-15
Form S-3 - Registration statement under Securities Act of 1933
2025-12-15 ·
Form S-3 - Registration statement under Securities Act of 1933
2025-11-26
Form 8-K - Current report
Key Events
2025-11-26 · Key Events
Form 8-K - Current report
2025-11-14
Form 8-K - Current report
Key Events
2025-11-14 · Key Events
Form 8-K - Current report
2025-11-14
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Financials
2025-11-14 · Financials
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025-11-12
Form 424B5 - Prospectus [Rule 424(b)(5)]
2025-11-12 ·
Form 424B5 - Prospectus [Rule 424(b)(5)]
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
